An endogenous inhibitor of human immunodeficiency virus in human lymphocytes is overcome by the viral Vif protein

被引:196
作者
Madani, N [1 ]
Kabat, D [1 ]
机构
[1] Oregon Hlth Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97201 USA
关键词
D O I
10.1128/JVI.72.12.10251-10255.1998
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The vif gene of human immunodeficiency virus type 1 (HIV-1) encodes a basic M-r 23,000 protein that is necessary for production of infectious virions by nonpermissive cells (human lymphocytes and macrophages) but not by permissive cells such as HeLa-CD4. It had been proposed that permissive cells may contain an unidentified factor that functions like the viral Vif protein. To test this hypothesis, we produced pseudotyped wild-type and vif-deleted HIV gpt virions (which contain the HIV-1 genome with the bacterial mycophenolic acid resistance gene gpt in place of the viral env gene) in permissive cells, and we used them to generate nonpermissive H9 leukemic T cells that express these proviruses. We then fused these H9 cells with permissive HeLa cells that express the HIV-1 envelope glycoprotein gp120-gp41, and we asked whether the heterokaryons would release infectious HIV gpt virions. The results clearly showed that the vif-deleted virions released by the heterokaryons were noninfectious whereas the wild-type virions were highly infectious. This strongly suggests that nonpermissive cells, the natural targets of HIV-1, contain a potent endogenous inhibitor of HIV-I replication that is overcome by Vif.
引用
收藏
页码:10251 / 10255
页数:5
相关论文
共 28 条
[1]  
Ausubel FM., 1994, Curr. Protoc. Mol. Biol
[2]   TRANSCOMPLEMENTATION OF VIF- HIV-1 MUTANTS IN CEM CELLS SUGGESTS THAT VIF AFFECTS LATE STEPS OF THE VIRAL LIFE-CYCLE [J].
BLANC, D ;
PATIENCE, C ;
SCHULZ, TF ;
WEISS, R ;
SPIRE, B .
VIROLOGY, 1993, 193 (01) :186-192
[3]   HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VIF(-) MUTANT PARTICLES FROM RESTRICTIVE CELLS - ROLE OF VIF IN CORRECT PARTICLE ASSEMBLY AND INFECTIVITY [J].
BORMAN, AM ;
QUILLENT, C ;
CHARNEAU, P ;
DAUGUET, C ;
CLAVEL, F .
JOURNAL OF VIROLOGY, 1995, 69 (04) :2058-2067
[4]   Phenotypically Vif(-) human immunodeficiency virus type 1 is produced by chronically infected restrictive cells [J].
Bouyac, M ;
Rey, F ;
Nascimbeni, M ;
Courcoul, M ;
Sire, J ;
Blanc, D ;
Clavel, F ;
Vigne, R ;
Spire, B .
JOURNAL OF VIROLOGY, 1997, 71 (03) :2473-2477
[5]   CD4 down-modulation during infection of human T cells with human immunodeficiency virus type 1 involves independent activities of vpu, env, and nef [J].
Chen, BK ;
Gandhi, RT ;
Baltimore, D .
JOURNAL OF VIROLOGY, 1996, 70 (09) :6044-6053
[6]   HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes [J].
Collins, KL ;
Chen, BK ;
Kalams, SA ;
Walker, BD ;
Baltimore, D .
NATURE, 1998, 391 (6665) :397-401
[7]   PERIPHERAL-BLOOD MONONUCLEAR-CELLS PRODUCE NORMAL AMOUNTS OF DEFECTIVE VIF(-) HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PARTICLES WHICH ARE RESTRICTED FOR THE PRERETROTRANSCRIPTION STEPS [J].
COURCOUL, M ;
PATIENCE, C ;
REY, F ;
BLANC, D ;
HARMACHE, A ;
SIRE, J ;
VIGNE, R ;
SPIRE, B .
JOURNAL OF VIROLOGY, 1995, 69 (04) :2068-2074
[8]   Human immunodeficiency virus type 1 Vif does not influence expression or virion incorporation of gag-, pol-, and env-encoded proteins [J].
Fouchier, RAM ;
Simon, JHM ;
Jaffe, AB ;
Malim, MH .
JOURNAL OF VIROLOGY, 1996, 70 (12) :8263-8269
[9]   ROLE OF VIF IN REPLICATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IN CD4+ T LYMPHOCYTES [J].
GABUZDA, DH ;
LAWRENCE, K ;
LANGHOFF, E ;
TERWILLIGER, E ;
DORFMAN, T ;
HASELTINE, WA ;
SODROSKI, J .
JOURNAL OF VIROLOGY, 1992, 66 (11) :6489-6495
[10]   Infected cell protein (ICP)47 enhances herpes simplex virus neurovirulence by blocking the CD8+ T cell response [J].
Goldsmith, K ;
Chen, W ;
Johnson, DC ;
Hendricks, RL .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (03) :341-348